Global Veterinary Diagnostics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Veterinary Diagnostics Market Analysis

The veterinary diagnostics market is experiencing significant growth driven by advancements in technology and an increasing focus on animal health and welfare. Recent developments in diagnostic techniques, such as molecular diagnostics, point-of-care testing, and advanced imaging, have revolutionized the way veterinarians diagnose and treat diseases in animals. For instance, the rise of rapid test kits allows for quick and accurate detection of infectious diseases, enabling timely interventions and improved outcomes. In addition, the integration of artificial intelligence and machine learning in diagnostic tools enhances the accuracy and efficiency of tests, further propelling market growth. The increasing prevalence of zoonotic diseases and the rising pet ownership trends are also contributing to the demand for innovative diagnostic solutions. Furthermore, regulatory support and investments in veterinary research are fostering the development of new diagnostic products and technologies. As pet owners become more aware of the importance of regular health check-ups and preventative care, the veterinary diagnostics market is poised for continued expansion, presenting lucrative opportunities for key players in the industry to innovate and enhance their offerings.

Veterinary Diagnostics Market Size

The global veterinary diagnostics market size was valued at USD 3.06 billion in 2023 and is projected to reach USD 5.91 billion by 2031, with a CAGR of  8.55% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Veterinary Diagnostics Market Trends

“Increasing Adoption of Point-Of-Care Testing (POCT) Solutions”

Рынок ветеринарной диагностики переживает устойчивый рост, обусловленный растущей распространенностью зоонозных заболеваний и растущей тенденцией владения домашними животными. Заметной тенденцией на рынке ветеринарной диагностики является растущее внедрение решений для тестирования в месте оказания помощи (POCT), которые обеспечивают быстрые и точные диагностические результаты в ветеринарной клинике или даже в полевых условиях. Этот сдвиг обусловлен растущим спросом на своевременную диагностику и лечение, что позволяет ветеринарам быстро принимать обоснованные решения. Например, такие компании, как Idexx Laboratories и Zoetis, разработали портативные диагностические устройства, которые позволяют проводить немедленное тестирование крови, мочи и других образцов, значительно сокращая время ожидания результатов. Удобство POCT повышает эффективность ветеринарной практики, улучшает результаты для пациентов, способствуя быстрому началу лечения. Более того, рост телемедицины в ветеринарной помощи еще больше повысил спрос на POCT, поскольку ветеринары могут удаленно оценить состояние питомца на основе немедленных результатов тестов. Эта тенденция подчеркивает важность инновационной диагностики для удовлетворения меняющихся потребностей как ветеринарных специалистов, так и владельцев домашних животных.

Область применения отчета и сегментация рынка ветеринарной диагностики       

Определение рынка ветеринарной диагностики

Ветеринарная диагностика относится к процессам и технологиям, используемым для выявления и оценки состояния здоровья, болезней и травм у животных. Эта область охватывает ряд диагностических инструментов и методов, включая лабораторные тесты, ветеринарную диагностическую визуализацию (например, рентген, ультразвук и МРТ) и клинические обследования, направленные на предоставление точной информации о состоянии здоровья животного. Анализируя биологические образцы, такие как кровь, моча и ткани, ветеринарная диагностика помогает ветеринарам принимать обоснованные решения относительно лечения и ухода.

Динамика рынка ветеринарной диагностики

Драйверы

• Рост числа владельцев домашних животных

Рост числа владельцев домашних животных является значительным драйвером рынка ветеринарной диагностики, поскольку все больше домохозяйств решают завести домашних животных в своих семьях. По данным Американской ассоциации товаров для домашних животных (APPA), примерно 70% домохозяйств США, или около 90,5 миллионов семей, имели домашних животных в 2021 году, что отражает устойчивый рост по сравнению с предыдущими годами. Этот всплеск числа владельцев домашних животных коррелирует с повышенным спросом на ветеринарные услуги, включая диагностику, поскольку владельцы все больше уделяют первостепенное внимание здоровью и благополучию своих животных. В результате ветеринары все чаще используют передовые диагностические инструменты для предоставления комплексного медицинского обслуживания, усиливая растущую тенденцию ответственного владения домашними животными и улучшения благополучия животных, тем самым стимулируя рост рынка.

• Рост распространенности зоонозных заболеваний

The increasing prevalence of zoonotic diseases is a critical driver in the veterinary diagnostics market, as it raises awareness about the need for effective diagnostic solutions in veterinary medicine. The World Health Organization (WHO) reports that approximately 60% of emerging infectious diseases are zoonotic, emphasizing the importance of monitoring animal health to protect public health. For instance, outbreaks of zoonotic diseases such as rabies and Lyme disease have highlighted the risks associated with animal-to-human transmission, leading to a greater demand for comprehensive veterinary diagnostics. The U.S. Centers for Disease Control and Prevention (CDC) Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, including those caused by bacteria, viruses, and parasites. Consequently, veterinary diagnostics play a vital role in early detection and management, helping to mitigate the risk of zoonotic diseases and enhance both animal and human health outcomes, ultimately driving the market growth.

Opportunities

• Increasing Technological Advancements

Technological advancements are revolutionizing the veterinary diagnostics market by incorporating cutting-edge tools such as artificial intelligence (AI) and machine learning (ML), which significantly enhance diagnostic accuracy and expedite results. For instance, AI algorithms can analyze medical images, such as X-rays or ultrasounds, to detect abnormalities with remarkable precision, often outperforming traditional methods. For instance, the use of AI-powered imaging software developed by companies such as Vetology AI, which assists veterinarians in identifying conditions such as fractures or tumors in pets more quickly than manual evaluations. Moreover, the deployment of machine learning models can facilitate the analysis of large datasets, helping veterinary practitioners make more informed decisions based on predictive analytics. As these technologies continue to evolve, they are poised to transform veterinary diagnostics by making them more efficient, accurate, and accessible, thereby creating opportunities in the market.

• Rising Supportive Government Initiatives

Government initiatives play a crucial role in enhancing the veterinary diagnostics market by implementing supportive regulations and programs focused on improving animal health and welfare. Such initiatives often lead to increased funding for veterinary services and diagnostics, ultimately driving demand. For instance, in the U.S., the Animal Health and Welfare Improvement Act has allocated significant resources toward the prevention and control of animal diseases, encouraging research and development in veterinary diagnostics. In addition, countries such as Australia have established the National Animal Health Surveillance System (NAHSS) to monitor and respond to animal health threats, which in turn fosters a higher demand for diagnostic testing and services. These government-backed efforts raise awareness of animal health issues and create a favorable environment for veterinary diagnostic providers, offering significant growth opportunities in the market.

Restraints/Challenges

• Shortage of Skilled Professionals

The veterinary diagnostics market faces a significant challenge due to the shortage of skilled professionals qualified to perform diagnostic procedures and interpret results accurately. This scarcity of trained veterinarians and technicians can adversely affect the quality of care provided to animals, leading to misdiagnoses or delays in treatment. This situation impacts the efficiency of diagnostic services and lead to longer wait times for pet owners seeking care for their animals. As the demand for veterinary services continues to rise alongside increasing pet ownership, this shortage of skilled professionals threatens to hinder the growth and effectiveness of veterinary diagnostics, ultimately affecting animal health and welfare.

• High Costs Associated with Diagnostic Tests

High costs associated with diagnostic tests present a significant challenge in the veterinary diagnostics market, particularly for small veterinary practices that may struggle to invest in advanced technologies. For instance, sophisticated imaging techniques such as MRI or CT scans can cost thousands of dollars, making it difficult for clinics with limited budgets to offer these essential services. This financial burden can lead to decreased access to crucial diagnostic procedures for pet owners, who may be unable to afford necessary tests for their animals. Consequently, this situation compromises the quality of care available to pets and hinders the overall growth of the veterinary diagnostics market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Veterinary Diagnostics Market Scope

The market is segmented on the basis of product, technology, animal type, disease type, species, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Instruments and Reagents
• Consumables

Technology

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Urinalysis
• Others

Animal Type

• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Livestock Animals
  • Cattle
  • Poultry
  • Swine
  • Other Production Animals

Disease Type

• Infectious Diseases
• Non-Infectious Diseases
• Hereditary Diseases
• Congenital Diseases
• Acquired Diseases
• General Ailments
• Structural and Functional Diseases

Species

• Bovine
• Camelid
• Canine and Feline
• Caprine
• Equine
• Ovine
• Porcine
• Avian
• Others

End User

• Reference Laboratories
• Veterinary Hospitals and Clinics
• Point-of-Care/In-House Testing
• Research Institutes
• Universities

Veterinary Diagnostics Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, technology, animal type, disease type, species, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America holds a leading position in the veterinary diagnostics market, primarily due to the availability of comprehensive healthcare programs tailored to support animal health. The region benefits from advanced veterinary practices, significant investments in research and development, and a robust regulatory framework that promotes innovation in diagnostic technologies. In addition, the growing awareness among pet owners about the importance of regular health check-ups for their animals further drives the demand for veterinary diagnostic services in North America.

Asia-Pacific (APAC) region is rapidly emerging as a significant player in the market, largely driven by substantial investments in healthcare infrastructure and a rising prevalence of chronic diseases. As healthcare systems in countries such as China and India modernize, the demand for advanced diagnostic solutions, including Veterinary Diagnostics, is expected to surge. Moreover, increasing awareness of the benefits of telemedicine, coupled with government initiatives promoting digital health solutions, is fostering greater acceptance of Veterinary Diagnostics services. This momentum is further supported by the presence of innovative companies and technological advancements in the region, positioning APAC for robust market growth in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Veterinary Diagnostics Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Veterinary Diagnostics Market Leaders Operating in the Market Are:

• Almac Group (U.K.)
• Element Materials Technology (U.K.)
• Eurofins Scientific (France)
• Thermo Fisher Scientific Inc (U.S.)
• Source BioScience (U.K.)
• Intertek Group plc (U.K.)
• Laboratory Corporation of America Holdings (U.S.)
• Charles River Laboratories (U.S.)
• WuXi AppTec (China)
• Anacura (Belgium)
• LGC Limited (U.K.)
• Medpace, Inc. (U.S.)
• Syneos Health (U.S.)
• STERIS (U.S.)
• Merck Group KGaA (Germany)

Latest Developments in Veterinary Diagnostics Market

• In January 2024, Center Point Bio-Tech, LLC (CPB) unveiled AlphaION at the 2024 Veterinary Meeting & Expo in the U.S. This innovative, patent-pending diagnostic system is designed specifically for veterinary practices
• In November 2023, Antech inaugurated a new veterinary diagnostics laboratory in Warwick, U.K., which will enhance the company’s laboratory network across the region. This state-of-the-art facility is equipped with advanced technology to provide comprehensive diagnostic services, improving turnaround times for test results
• In March 2023, QIAGEN N.V. formed a partnership with Servier to create a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor. This solution was launched for the treatment of Acute Myeloid Leukemia (AML), a type of blood cancer. As part of this collaboration, QIAGEN will develop and validate a real-time in vitro PCR test for detecting IDH1 gene mutations in AML patients using whole blood and bone marrow aspirates
• In August 2022, PepiPets introduced a new mobile diagnostic testing service, enabling clients to obtain diagnostic testing for their pets in the comfort of their own homes. The company aims for this at-home testing service to enhance pet comfort during procedures and reduce the time spent traveling to in-person office visits
• In March 2022, Companion Animal Health established a strategic partnership, which includes an equity investment, with HT BioImaging to co-brand and exclusively market the HTVet product in the U.S. and Canada

SKU-10450